Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2020 | 1 |
2021 | 2 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Use of Botulism Antitoxin Heptavalent (A, B, C, D, E, F, G)-(Equine) (BAT®) in Clinical Study Subjects and Patients: A 15-Year Systematic Safety Review.
Toxins (Basel). 2021 Dec 27;14(1):19. doi: 10.3390/toxins14010019.
Toxins (Basel). 2021.
PMID: 35050996
Free PMC article.
Results of a Double-Blind, Randomized, Placebo-Controlled Phase 1 Study to Evaluate the Safety and Pharmacokinetics of Anti-Zika Virus Immunoglobulin.
White J, Tunga P, Anderson DM, Iledan K, Loreth T, Parrera GS, Astacio H, Drobic B, Richardson JS.
White J, et al. Among authors: astacio h.
Am J Trop Med Hyg. 2021 Oct 4;105(6):1552-1562. doi: 10.4269/ajtmh.20-1578.
Am J Trop Med Hyg. 2021.
PMID: 34610572
Free PMC article.
Clinical Trial.
Item in Clipboard
Safety and Clinical Outcomes of an Equine-derived Heptavalent Botulinum Antitoxin Treatment for Confirmed or Suspected Botulism in the United States.
Richardson JS, Parrera GS, Astacio H, Sahota H, Anderson DM, Hall C, Babinchak T.
Richardson JS, et al. Among authors: astacio h.
Clin Infect Dis. 2020 Apr 15;70(9):1950-1957. doi: 10.1093/cid/ciz515.
Clin Infect Dis. 2020.
PMID: 31209461
Item in Clipboard
Cite
Cite